by EPHA | Nov 17, 2015 | Medicines, health technology and health information
Join EPHA, Health Care Without Harm, and MEP hosts Martin Hausling (Greens/EFA) and Jasenko Selimovic (ALDE) to discuss a long-neglected cause of antimicrobial resistance (AMR) – pollution of the natural environment arising from irresponsible antibiotic...
by EPHA | Oct 9, 2015 | Medicines, health technology and health information
EPHA, together with US consumer organisation SumOfUs and UK-based Ethical Consumer, has co-signed letters to some of the world’s leading pharmaceutical companies, asking for information on their sources of active pharmaceutical ingredients (APIs) and their...
by EPHA | Oct 9, 2015 | Digital Health | Publications, Medicines, health technology and health information
The General Data Protection Reform (GDPR) entered into the trilogue phase in June with the aim of concluding discussions at the end of 2015 or soon thereafter. A new EPHA progress report describes the challenges of the GDPR experienced so far and confirms the crucial...
by EPHA | Oct 9, 2015 | Medicines, health technology and health information
eHealth, mobile apps and digital medical services are sparking many hopes and concerns at the same time. The #Datacare debate held on 15 September 2015 at the European Parliament specifically explored the question, “What can data driven healthcare do for...
by EPHA | Aug 28, 2015 | Medicines, health technology and health information
On 15 July 2015 EPHA and Wemos hosted an event in the Members’ Salon at the European Parliament to highlight the issue of added therapeutic value (ATV) in medicines. Several studies carried out at EU member state level indicate that the majority of medicines...
by EPHA | Aug 3, 2015 | Medicines, health technology and health information
Public health is not just about human diseases, healthcare services or cross-border pandemics. Most of all, health is about people. Giving wider attention to the individual also fits perfectly with the European 2020 vision of ‘smart, inclusive and...
